| Breakdown | TTM | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 367.15M | 373.19M | 334.60M | 239.88M | 364.00M | 226.19M |
| Gross Profit | 100.71M | 98.56M | 89.41M | 85.45M | 93.31M | 60.24M |
| EBITDA | 53.39M | 55.15M | 55.40M | 56.09M | 58.27M | 29.09M |
| Net Income | 23.53M | 19.81M | 31.58M | 36.01M | 40.80M | 25.02M |
Balance Sheet | ||||||
| Total Assets | 436.63M | 440.50M | 442.88M | 340.05M | 340.81M | 279.38M |
| Cash, Cash Equivalents and Short-Term Investments | 143.24M | 137.72M | 134.71M | 143.42M | 81.41M | 87.17M |
| Total Debt | 13.56M | 16.09M | 32.68M | 4.01M | 2.22M | 2.98M |
| Total Liabilities | 122.27M | 132.68M | 153.64M | 55.85M | 70.22M | 37.83M |
| Stockholders Equity | 279.03M | 274.78M | 264.97M | 251.39M | 235.38M | 207.57M |
Cash Flow | ||||||
| Free Cash Flow | 57.90M | 21.04M | 7.86M | 93.33M | 2.64M | -9.94M |
| Operating Cash Flow | 59.33M | 25.61M | 10.61M | 119.30M | 19.99M | 19.98M |
| Investing Cash Flow | -17.67M | 4.25M | 18.09M | -95.08M | -11.97M | 14.43M |
| Financing Cash Flow | -21.61M | -32.86M | -19.84M | -29.86M | -15.79M | -10.56M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
72 Outperform | HK$150.00M | 2.65 | 8.50% | 6.71% | 2.81% | 23.68% | |
67 Neutral | HK$234.00M | 8.58 | 4.53% | 9.50% | -13.58% | -41.25% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% | |
53 Neutral | HK$149.29M | -6.80 | -2.23% | ― | -11.79% | 25.41% | |
43 Neutral | HK$153.45M | 3.99 | 3.67% | ― | 17.91% | ― | |
41 Neutral | HK$54.87M | -1.91 | -4753.10% | ― | -10.03% | -3133.33% | |
39 Underperform | HK$70.49M | -0.83 | -83.05% | ― | -74.22% | 23.27% |